Avanos Medical, Inc. Announces Second Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Avanos Medical, Inc. (AVNS) Tops Q2 EPS by 23c
August 4, 2020 7:06 AM EDTAvanos Medical, Inc. (NYSE: AVNS) reported Q2 EPS of $0.13, $0.23 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $164 million versus the consensus estimate of $147.9 million.
"We're pleased we continue to meet the needs of patients during the pandemic, as... More
